Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
Business

Biocon founder Kiran Mazumdar Shaw says India must shift pharma industry from generics to innovation-led growth

New Delhi: India must move beyond its success in generic medicines and build an innovation-led pharmaceutical industry by strengthening research, speeding up regulatory approvals and consistently investing in new drug development, Biocon and Syngene International Executive Chairperson Kiran Mazumdar-Shaw said on Tuesday.

Speaking virtually at the Indian Foundation for Quality Management (IFQM) Symposium 2026, Mazumdar-Shaw said India had the talent and capabilities to take innovations from laboratories to clinical development and commercial markets, but needed a credible ecosystem to compete with global leaders.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.